MBTPS1 and multiple system atrophy: In animal models of the synucleinopathies PD and MSA administration of FTY720, an S1P agonist, has been shown to ameliorate neurodegeneration and behavioral dysfunction associated with mitochondrial dysfunction via S1P receptors [45, 46].